Investigating the link between glucose, lipids, and brain aging

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between glucose and lipid metabolism and brain aging-related conditions, such as mild cognitive impairment, in a community-based population aged 50 and older. A survey will be conducted involving 10,000 participants from various geographic regions to assess whether abnormalities in glucose and lipid levels are risk factors for cognitive decline. The study will not involve any interventions but will focus on gathering data to better understand these metabolic factors in relation to brain health.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age \>= 50 years old;
2. Gender: males and females;
3. Provide written informed consent;
4. Satisfactory compliance.

Exclusion Criteria:

1. Pregnant or lactating women
2. No history of addiction or neurological, psychiatric, or systemic diseases known to affect cognitive function, including head trauma, subdural hematoma, current depression, and epilepsy
3. Any other condition or major systemic diseases that the investigator feels would interfere with trial participation or evaluation of results.

Where it's running

• Shandong Provincial Hospital Affiliated to Shandong First Medical University
  Jinan, Shandong, China Recruiting

Study contacts

• Study coordinator: Ling Gao
• Email: gaoling1@medmail.com.cn
• Phone: +8613793187189

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tislelizumab plus chemotherapy to convert unresectable locally advanced esophageal squamous cell carcinoma to surgery

  This study will try whether adding the immune drug tislelizumab to chemotherapy can shrink tumors so people with initially unresectable locally advanced esophageal squamous cell carcinoma can become eligible for surgery.

  Recruiting Shandong Provincial Hospital · Jinan, Shandong · NCT07549100

• Cardiac MRI-based prediction tool for outcomes in dilated cardiomyopathy

  This project will test whether adding multi-parameter stress perfusion cardiac MRI to routine clinical data can better predict which people with dilated cardiomyopathy will go on to develop heart failure, arrhythmias, hospitalizations, or death.

  Recruiting Shandong Provincial Hospital · Jinan, Shandong · NCT07527715

• Short-course vs long-course radiotherapy followed by the PD-L1 drug adebrelimab plus CAPEOX before surgery for locally advanced rectal cancer

  This trial will test whether adding the PD‑L1 drug adebrelimab to either short‑course or long‑course radiotherapy plus CAPEOX chemotherapy before surgery helps patients with locally advanced, MSS rectal cancer.

  Recruiting Phase 2 Shandong Provincial Hospital · Jinan, Shandong · NCT07284992

• One-day nature-based tourism to reduce symptoms in major depressive disorder

  This project will test whether adding a one-day nature-based tourism activity to usual medication helps reduce depressive symptoms in adults with major depressive disorder.

  Recruiting Shandong Provincial Hospital · Jinan, Shandong and 1 other locations · NCT07180342

• Neoadjuvant therapy for esophageal cancer

  This study is testing a new combination of treatments for patients with advanced esophageal cancer to see if it can help shrink tumors before surgery.

  Recruiting Phase 2 Shandong Provincial Hospital · Jinan, Shandong · NCT06908382

• Iparomlimab and Tuvonralimab (QL1706) plus SOX versus SOX alone for locally advanced gastric or gastroesophageal junction adenocarcinoma

  This trial will test whether adding the immunotherapy combination Iparomlimab and Tuvonralimab (QL1706) to standard SOX chemotherapy before and after surgery helps people with locally advanced gastric or gastroesophageal junction adenocarcinoma achieve complete tumor remission.

  Recruiting Phase 2 Shandong Provincial Hospital · Jinan, Shandong · NCT06829797

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.